2-hexynyladenosine-5'-n-ethylcarboxamide has been researched along with cyproterone acetate in 1 studies
| Studies (2-hexynyladenosine-5'-n-ethylcarboxamide) | Trials (2-hexynyladenosine-5'-n-ethylcarboxamide) | Recent Studies (post-2010) (2-hexynyladenosine-5'-n-ethylcarboxamide) | Studies (cyproterone acetate) | Trials (cyproterone acetate) | Recent Studies (post-2010) (cyproterone acetate) |
|---|---|---|---|---|---|
| 28 | 0 | 2 | 1,845 | 339 | 261 |
| Protein | Taxonomy | 2-hexynyladenosine-5'-n-ethylcarboxamide (IC50) | cyproterone acetate (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.225 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.225 | |
| Androgen receptor | Homo sapiens (human) | 0.1408 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.339 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.225 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.225 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.225 | |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.045 | |
| Mu-type opioid receptor | Homo sapiens (human) | 2.183 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abiru, T; Homma, H; Matsuda, A; Murayama, T; Nomura, Y; Watanabe, Y | 1 |
1 other study(ies) available for 2-hexynyladenosine-5'-n-ethylcarboxamide and cyproterone acetate
| Article | Year |
|---|---|
Nucleosides and nucleotides. 112. 2-(1-Hexyn-1-yl)adenosine-5'-uronamides: a new entry of selective A2 adenosine receptor agonists with potent antihypertensive activity.
Topics: Adenosine; Animals; Antihypertensive Agents; Brain; Male; Molecular Structure; Rats; Rats, Inbred SHR; Receptors, Purinergic; Substrate Specificity | 1992 |